Bylvay

Generic name: Odevixibat
Dosage form: oral pellet, oral capsule
Drug class: Miscellaneous GI agents

Usage of Bylvay

Bylvay (odevixibat) is an oral capsule that may be used to treat itching (pruritus) caused by progressive familial intrahepatic cholestasis (PFIC; a genetic disorder) in adults and children 3 months of age and older. A limitation of use is that it may not be effective in PFIC2, a subtype of PFIC caused by mutations in the ABCB11 gene.

Bylvay may also be used to treat cholestatic pruritus in patients 12 months of age and older with Alagille syndrome (ALGS).

Although the exact way Bylvay works to reduce itching in patients with PFIC or Alagille syndrome is unknown, it is thought to be due to a reduction in serum bile acids. Bylvay is an ileal bile acid transporter (IBAT) inhibitor that decreases the reabsorption of bile acids (mainly the salt forms) from the terminal ileum (this is the end segment of the small intestine). This results in lower levels of bile acids in the blood.

Progressive familial intrahepatic cholestasis (PFIC) and cholestatic pruritus due to Alagille syndrome are conditions caused by genetic mutations that cause impaired bile flow. The subsequent toxic build-up of bile acids can lead to pruritus, which can be severe and debilitating.

Bylvay side effects

Get emergency medical help if your child has signs of an allergic reaction: hives; difficulty breathing; swelling of the face, lips, tongue, or throat.

Call your doctor at once if your child has:

severe or ongoing diarrhea, black or bloody stools

rapid weight gain, stomach pain, and bloating

vomiting large amounts of blood

confusion, trouble concentrating, sleep problems, feeling anxious or irritable

slurred speech, problems with balance or coordination

uncontrolled muscle movement in the hands

increased thirst, decreased urination or sweating

a light-headed feeling

changes in mood or behavior or

new or worsening liver problems--loss of appetite, stomach pain (upper right side), tiredness, bruising or bleeding, increased itching, jaundice (yellowing of the skin or eyes).

Common side effects of Bylvay may include:

stomach pain, diarrhea, vomiting

abnormal liver function tests or

deficiency in vitamins A, D, E, or K.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before taking Bylvay

You should not give Bylvay to a child who is on a liquid diet.

Tell your child's doctor if the child has ever had cirrhosis.

There is a pregnancy safety study that collects pregnancy outcome data in women taking Bylvay during pregnancy. Pregnant women exposed to Bylvay, or their healthcare providers, should report exposure by calling 1-855-252-4736.

Relate drugs

How to use Bylvay

Recommended dosage for PFIC for patients 3 months and older: 40 mcg/kg taken once a day.

Recommended dosage for ALGS for patients 12 months and older: 120 mcg/kg once a day.

Doses are based on weight. Your child's dose may change if the child gains or loses weight.

Warnings

There are no contraindications to the use of Bylvay.

May not be effective in PFIC type 2 patients with ABCB11variants resulting in non-functional or complete absence of bile salt export pump protein (BSEP-3).

May cause liver test abnormalities. Your doctor will conduct liver tests before and during treatment with Bylvay. Dose reduction or treatment interruption may be required if abnormalities occur and treatment discontinuation should be considered for persistent or recurrent abnormalities.

Diarrhea may occur. Treat dehydration and withhold or discontinue treatment for persistent diarrhea.

Can cause fat-soluble vitamin (FSV) deficiency. Doctors should obtain baseline levels of fat-soluble vitamins and monitor them during treatment. Doctors should supplement if a deficiency is observed, but if the deficiency persists or worsens, then they should discontinue treatment.

What other drugs will affect Bylvay

Give the Bylvay dose 4 hours before or 4 hours after giving any of the following:

cholestyramine

colesevelam or

colestipol.

Other drugs may affect Bylvay, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.